Fibrinolysin is an enzyme that cleaves fibrin, a key protein in blood clots.
纤维蛋白溶酶是一种分解血栓中关键蛋白质纤维蛋白的酶。
The use of
fibrinolysin in medicine helps to dissolve blood clots and restore blood flow.
在医学上使用纤维蛋白溶酶有助于溶解血栓并恢复血液流动。
Fibrinolysis is a natural process that occurs during the breakdown of blood clots after injury or surgery.
纤维蛋白溶解是损伤或手术后血栓破裂过程中的自然现象。
Fibrinolytic therapy is often administered to patients with deep vein thrombosis to prevent pulmonary embolism.
对深静脉血栓患者的纤维蛋白溶解疗法常用于预防肺栓塞。
Fibrinolysin can be found in certain bacteria and snakes as a defense mechanism to break down tissue barriers.
纤维蛋白溶酶在某些细菌和蛇中被发现,作为防御机制来分解组织屏障。
In the laboratory, researchers study
fibrinolysin for its potential applications in treating cardiovascular diseases.
实验室里的研究人员研究纤维蛋白溶酶,因其可能在心血管疾病治疗中发挥作用。
The excessive activation of
fibrinolysin can lead to uncontrolled bleeding, which is a medical emergency.
纤维蛋白溶酶过度激活可能导致无法控制的出血,这是一种医疗紧急情况。
The effectiveness of fibrinolysis depends on the specific type of enzyme used and the target site within the clot.
纤维蛋白溶解的效果取决于使用的特定酶类型以及在血栓中的目标位置。
Physicians carefully monitor fibrinolysis treatment, as it can interact with other medications and increase bleeding risk.
医生在监控纤维蛋白溶解治疗时需谨慎,因为它可能与其他药物相互作用并增加出血风险。
Researchers are exploring the use of synthetic
fibrinolysins as a safer alternative to natural enzymes for certain medical procedures.
研究人员正在探索合成纤维蛋白溶酶作为某些医疗程序中更安全的天然酶替代品。
未经许可,严禁转发。QQ交流群:688169419